MYX 0.22% $4.61 mayne pharma group limited

Correction, its "phase 2(b) clinical trial", with a "Type-C...

  1. 6,633 Posts.
    lightbulb Created with Sketch. 615
    Correction, its "phase 2(b) clinical trial", with a "Type-C Guidance Meeting" scheduled, which i think is about going to the next stage, but apparently stage4 is the big one that can take many years. So its long way from getting return, a big percentage dont get final approval.
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.